Literature DB >> 5668036

Endotoxin-induced resistance to a staphylococcal infection: cellular and humoral responses compared in two mouse strains.

B M Sultzer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5668036     DOI: 10.1093/infdis/118.3.340

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  6 in total

1.  Commercial preparations of lipoteichoic acid contain endotoxin that contributes to activation of mouse macrophages in vitro.

Authors:  J J Gao; Q Xue; E G Zuvanich; K R Haghi; D C Morrison
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

2.  Passive protection of mice against Pseudomonas aeruginosa by serum from recently vaccinated mice.

Authors:  R J Jones; H A Lilly; E J Lowbury
Journal:  Br J Exp Pathol       Date:  1971-06

3.  Toll-like receptor 4-deficient mice have reduced bone destruction following mixed anaerobic infection.

Authors:  L Hou; H Sasaki; P Stashenko
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

4.  Toll-like receptor 4-defective C3H/HeJ mice are not more susceptible than other C3H substrains to infection with Mycobacterium tuberculosis.

Authors:  Arati B Kamath; Jennifer Alt; Hajer Debbabi; Samuel M Behar
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

5.  A uropathogenic E. coli UTI89 model of prostatic inflammation and collagen accumulation for use in studying aberrant collagen production in the prostate.

Authors:  Hannah Ruetten; Jaskiran Sandhu; Brett Mueller; Peiqing Wang; Helen L Zhang; Kyle A Wegner; Mark Cadena; Simran Sandhu; Lisa L Abler; Jonathan Zhu; Chelsea A O'Driscoll; Britta Chelgren; Zunyi Wang; Tian Shen; Jonathan Barasch; Dale E Bjorling; Chad M Vezina
Journal:  Am J Physiol Renal Physiol       Date:  2020-11-02

6.  Characterization of Toll-like receptor-4 (TLR-4) in the spleen and thymus of Swiss albino mice and its modulation in experimental endotoxemia.

Authors:  Chandrayee Ghosh; Biswadev Bishayi
Journal:  J Immunol Res       Date:  2015-02-05       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.